Can concurrent antibiotic treatment of sexual partners improve outcomes for women being treated for bacterial vaginosis?

2017 ◽  
Author(s):  
Jairo Amaya-Guio ◽  
David Andres Viveros-Carreño ◽  
Eloisa Mercedes Sierra-Barrios ◽  
Mercy Yolima Martinez-Velasquez ◽  
Carlos F Grillo-Ardila

Author(s):  
J Amaya-Guio ◽  
CF Grillo-Ardila ◽  
DA Viveros-Carreño ◽  
EM Sierra-Barrios

Author(s):  
Jairo Amaya-Guio ◽  
Mercy Yolima Martinez-Velasquez ◽  
David Andres Viveros-Carreño ◽  
Eloisa Mercedes Sierra-Barrios ◽  
Carlos F Grillo-Ardila

2018 ◽  
pp. 100-106
Author(s):  
P.V. Fedorich ◽  

Study of protozoyny invazions of the uroganital system with combination of microorganisms which are associated with bacterial vaginosis by women of fertil age and their sexual partners men is perspective direction of modern medicine. The development of this direction can increase the level of diagnostic inspection of patients by transmissible mainly sexual way infections and improve of efficiency of their treatment. The objective: exposure of combine defeats of uroganital system with different kinds of trichomonas or lamblias and microorganisms which are associated with bacterial vaginosis, for the women of fertil age and their sexual partners – men. All patients have infections, transmissible mainly sexual way with a chronic process and their treatment. Materials and methods. The special research of biomaterial, taken from the urogenital system of women of fertil age and their sexual partners-men, patients infections, transmissible mainly sexual way with a chronic process is conducted. 198 patients were inspected in clinic. Used the method of PCR, amplifier of DT-96, reagents of «Femoflor-16», praymeris for the indication of Trichomonas vaginalis, Trichomonas tenax, Pentatrichomonas hominis and Giardia lamblia. Results. Protozoyny invasions of the urogenital system determined at 88 (44.4%) of patients. At 77 (38.8%) from them determined the differet kinds of trichomonadies: Trichomonas tenax – at 41 (20.7%), Pentatrichomonas hominis – at 28 (14.1%), Trichomonas vaginalis – at 8 (4%). Giardia lamblia determined from 11 patients (5.6%). For 92% inspected patients with a protozoal invasions were determined the increassng of indexes of microflora, associated with bacterial vaginosis. The treatment of combine pathology of urogenital system which are caused different kinds trichomonades and microorganisms, which associated with BV, were conducted with etiotropic therapy. Seknidox used 2 tablets one time per day during 5 days. Orcipol used 1 tablets 3 or 2 times per a day (depending on weight) during 10 days. In research took part 56 patients with chronic ITSW. By 54 patients (96.4%) were eliminated of trichomonas. The normalization microflora’s level is attained for a 31 (57.4%) patient. Decrease of mocroflora’s, which associated with BV is marked by 24 patients (42.6%). Conclusions. This original method of treatment, is effective, has satisfactory bearableness and can be recommended for empiric therapy of combined pathology of urogenital system, caused of protozoyny invasions (different kinds of trichomonas) and microorganisms, associated with bacterial vaginosis, for the women of fertil age and their sexual partners with chronic infections, transmissible mainly sexual a way. This agents have a certain role in development of diseases of the urogenital system. Key words: Trichomonas vaginalis, Trichomonas tenax, Pentatrichomonas hominis, Giardia lamblia, invasion, fertil age.


2020 ◽  
Vol 5 (3) ◽  
pp. 66-76
Author(s):  
S. V. Barinov ◽  
V. A. Okhlopkov ◽  
Yu. I. Tirskaya ◽  
T. S.-K. Babaeva ◽  
L. В. Sinel'nikova ◽  
...  

Aim. To evaluate the genital microbiota of sexual partners of women with bacterial vaginosis and its role in the development of its recurrences. Materials and Methods. We examined 59 consecutive patients with bacterial vaginosis. In the treatment group, sexual partners of the female patients were treated by local delivery of clindamycin; in the comparison group, sexual partners did not receive the drug. All women included in the study received the same therapy: metronidazole per os and local delivery of clindamycin at the stage 1 and local delivery of lactic acid at the stage 2. All patients were examined by microscopy, PCR test, and inoculation of the genital discharge. Monitoring of the female patients with bacterial vaginosis was continued for 6 months. Results. In male patients, genital microbiota was similar to their female partners. Gardnerella vaginalis was detected in 96% of females and 62% of males. Prevotella was identified in 93% of females and 41% of males while Atopobium vaginae was found in 79% of women and 48% of their sexual partners. The amount of bacterial species was similar in males and females of the treatment group. The most frequent microorganisms were Escherichia coli, Staphylococcus spp. and Enterococcus faecalis. Female patients of the treatment group had two-fold lower risk of recurrent bacterial vaginosis than those of the comparison group. Conclusion. Genital microbiota of sexual partners may be responsible for the recurrent bacterial vaginosis in females, and parallel treatment of sexual partners is required to minimize its risk.


2020 ◽  
pp. 21-24
Author(s):  
A.D. Krutikova

Patients with bacterial vaginosis are diagnosed with chronic generalized inflammatory and inflammatory-dystrophic periodontal diseases, such as chronic catarrhal gingivitis, periodontitis of initial and first severity. The aim of the study was to compare the effectiveness of the treatment of inflammatory and inflammatory-dystrophic periodontal diseases in women with bacterial vaginosis and their sexual partners. Materials and methods. 28 heterosexual couples aged 18-45 years took part in the survey. Clinical dental examination was performed at the time of treatment and 3 months after completion of treatment. Green-Vermilion indices, RMA (in Parma modification), complex periodontal index according to Leus (KPI), Svrakov's number were determined. Both groups of patients were examined for the presence of Gardnerella vaginalis and Atopobium vaginae in the oral cavity by PCR testing. The therapeutic course was the same for all groups of patients. General therapy included: "Fluconazole" 50 mg 1 time per day (7 days), "Clindamycin" 150 mg every 6 hours (5 days), starting from the 3rd day of antibiotics - probiotic "Symbiter acidophilus concentrated "(21 days), Calcium-D3-Nycomed 1 tab. during dinner 30 days. Local treatment included: oral baths of the drug "Stomatophyte" after morning and evening hygienic procedures (7 days), application of "Metrogil-dent" on the gums (7 days), the drug "Lizak" 1 tab. keep in the mouth until complete dissolution every 6 hours (5 days), after the use of "Stomatophyte" and "Metrogil - dent" - application of "Symbiter omega" on the gums in silicone caps at night (21 days). Results. In women, chronic generalized catarrhal gingivitis was detected in 10.71%, chronic generalized periodontitis of the initial degree in 64.29% and chronic generalized periodontitis of the I degree in 25%. In men who are carriers of pathogens of BV, chronic generalized catarrhal gingivitis was found in 7.14%, chronic generalized periodontitis of the initial degree in 60.71% and chronic generalized periodontitis in grade 32.1. General and local dental treatment of women with bacterial vaginosis and their sexual partners showed a positive objective dynamics of dental status. Thus, after 3 months of clinical and laboratory observations, there were no complaints, the state of oral hygiene improved significantly. If before the treatment the Green-Vermilion index in general in women with BV was 1.323 ± 0.035 points, then after 3 months it was equal to 1.032 ± 0.021. A similar dynamics was determined in men: from the starting index of 1.336 ± 0.041, the Green-Vermilion index decreased to 1.048 ± 0.036. 3 months after treatment, the PMA of patients decreased by 49.03%, in men - by 51.95%, no significant difference between the indicators of groups I and II was registered, while the difference between the results in the middle of groups I and II is significant . According to the KPI index, women had a significant difference between baseline and post-treatment outcomes of 1.98 points, while men had a score of 2.01 points. No significant difference was found between the results of groups I and II both before and after treatment. A similar positive dynamics characterizes the indicator - Srakov's number, according to this indicator before treatment and after differences between groups was not detected. The significant difference between the indicators in the group of women and men was 2,789 and 2,831, respectively. Before treatment and after the detection rate in the oral cavity, Gardnerella vaginalis and Atopobium vaginae did not have a significant difference between the group of men and women, but there was a clear difference between the parameters obtained at the initial examination and 3 months after treatment in the middle and second groups. Thus, Gardnerella vaginalis was detected less by 67.87% and 61.59%, Atopobium vaginae - by 65.79% and 58.65% in women and men, respectively. Conclusions. The developed and patented treatment regimen for patients with bacterial vaginosis contributes to the regression of inflammatory phenomena, improves oral hygiene, and is suitable for the treatment of women with this comorbidity and for the treatment of their sexual partners. The dynamics of reducing the percentage of detection of bacterial vaginosis pathogens corresponded to the dynamics of the clinical picture of periodontal disease in both women with bacterial vaginosis and men who were their sexual partners, which once again confirms the equal effectiveness of treatment for both gender groups.


2003 ◽  
Vol 188 (3) ◽  
pp. 752-758 ◽  
Author(s):  
Harald Leitich ◽  
Mathias Brunbauer ◽  
Barbara Bodner-Adler ◽  
Alexandra Kaider ◽  
Christian Egarter ◽  
...  

Author(s):  
Romy D. Zwittink ◽  
Ellen H. A. van den Munckhof ◽  
Maurine A. Leverstein-van Hall ◽  
Kim Boers ◽  
Anco Molijn ◽  
...  

Abstract Bacterial vaginosis (BV) is perceived as a condition of disrupted vaginal microbiota, but remains of unknown aetiology. In this study, vaginal microbiota composition was determined in twenty-one women with BV, before and after treatment with metronidazole or clindamycin. Microbiota composition varied greatly between women and defining a (un)healthy vaginal microbiota state remains elusive, challenging BV diagnosis and treatment. While relative abundance of Lactobacillus increased after antibiotic treatment in two-third of women, its abundance was not associated with treatment outcome. Instead, remaining complaints of abnormal vaginal discharge were more common after metronidazole treatment and associated with increased relative abundance of Ureaplasma.


Microbiome ◽  
2017 ◽  
Vol 5 (1) ◽  
Author(s):  
Cornelia Gottschick ◽  
Zhi-Luo Deng ◽  
Marius Vital ◽  
Clarissa Masur ◽  
Christoph Abels ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document